IMLOVYD Trademark

Trademark Overview

On Wednesday, December 14, 2011, a trademark application was filed for IMLOVYD with the United States Patent and Trademark Office. The USPTO has given the IMLOVYD trademark a serial number of 85495426. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, July 5, 2019. This trademark is owned by Celgene Corporation. The IMLOVYD trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system; pharmaceutical preparations for the treatment of certain cancer and blood diseases
imlovyd

General Information

Serial Number85495426
Word MarkIMLOVYD
Filing DateWednesday, December 14, 2011
Status710 - CANCELLED - SECTION 8
Status DateFriday, July 5, 2019
Registration Number4252846
Registration DateTuesday, December 4, 2012
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 18, 2012

Trademark Statements

Goods and Servicespharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system; pharmaceutical preparations for the treatment of certain cancer and blood diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, July 5, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCelgene Corporation
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901
Party NameCelgene Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901
Party NameCelgene Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901

Trademark Events

Event DateEvent Description
Friday, July 5, 2019CANCELLED SEC. 8 (6-YR)
Monday, December 4, 2017COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, July 28, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, July 28, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, December 4, 2012REGISTERED-PRINCIPAL REGISTER
Tuesday, September 18, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 18, 2012PUBLISHED FOR OPPOSITION
Wednesday, August 29, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, August 15, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, August 13, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, August 13, 2012EXAMINER'S AMENDMENT ENTERED
Monday, August 13, 2012NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, August 13, 2012EXAMINERS AMENDMENT E-MAILED
Monday, August 13, 2012EXAMINERS AMENDMENT -WRITTEN
Saturday, August 11, 2012TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, August 11, 2012CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, August 11, 2012TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, April 11, 2012NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, April 11, 2012LETTER OF SUSPENSION E-MAILED
Wednesday, April 11, 2012SUSPENSION LETTER WRITTEN
Wednesday, April 11, 2012TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, April 11, 2012CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, April 6, 2012ASSIGNED TO LIE
Monday, March 26, 2012TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, March 23, 2012NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, March 23, 2012NON-FINAL ACTION E-MAILED
Friday, March 23, 2012NON-FINAL ACTION WRITTEN
Thursday, March 22, 2012ASSIGNED TO EXAMINER
Wednesday, December 21, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, December 17, 2011NEW APPLICATION ENTERED IN TRAM

Related Keywords

imlovyd pharmaceutical preparations certain treatment blood diseases system cancer modulate namely